Results 151 to 160 of about 56,684 (297)

Diagnostic Performance of Recombinant Peanut Allergens in Children: sIgE Cut‐Offs and Anaphylaxis Risk

open access: yesActa Paediatrica, EarlyView.
Diagnostic performance of recombinant peanut allergens for anaphylaxis risk in children. (A) Study population and clinical group. (B) Component‐specific IgE cut‐offs and associated odds ratios. (C) Forest plot of odds ratios for anaphylaxis. (D) Clinical interpretation of component‐specific IgE cut‐offs. ABSTRACT Aim Component‐resolved diagnostics (CRD)
Lisa Gazzolari   +10 more
wiley   +1 more source

Factors Associated With Omalizumab Response in Chronic Spontaneous Urticaria: Are There Age‐Related Differences?

open access: yesActa Paediatrica, EarlyView.
ABSTRACT Aim This study aimed to explore clinical and laboratory markers of omalizumab response in paediatric and adult chronic spontaneous urticaria (CSU) patients. Methods The study included 32 children and 67 adults with CSU receiving omalizumab, and 29 paediatric and 30 adult healthy controls; associations with treatment response were evaluated ...
Güler Yıldırım Nalbant   +14 more
wiley   +1 more source

Allergenicity of α‐Gal‐Containing Products

open access: yes
Allergy, EarlyView.
Frederik Bloch Mangaard   +4 more
wiley   +1 more source

A Real‐World Controlled Multicentre Study Evaluating the Association Between Benralizumab Therapy and Major Outcomes in Severe Asthma

open access: yesClinical &Experimental Allergy, EarlyView.
Among patients with severe eosinophilic asthma, benralizumab was associated with greater improvements in asthma outcomes—such as improved asthma control, quality of life and remission rates—compared to biologic‐naïve patients. ABSTRACT Background Real‐world data on benralizumab in patients with severe eosinophilic asthma–while controlling for ...
Dennis Thomas   +23 more
wiley   +1 more source

Berberine Inhibits Eczematous Skin <i>S. aureus</i>-Induced Mast Cell/Basophil Activation and Modulates MAPK-Associated Gene Expression. [PDF]

open access: yesInt J Mol Sci
Maskey AR   +14 more
europepmc   +1 more source

Emerging Paediatric Uses of Dupilumab Beyond Approvals

open access: yesClinical &Experimental Allergy, EarlyView.
Dupilumab, through IL‐4Rα blockade, shows promising efficacy beyond approved indications in paediatric diseases driven by T2 inflammation. Emerging evidence—mainly from small studies—supports improvements in disease severity and quality of life, highlighting its potential as a targeted, steroid‐sparing therapy while underscoring the need for ...
Simone Foti Randazzese   +11 more
wiley   +1 more source

IgE levels correlate with Fc<i>ε</i>RI expression on circulatory basophils but not with their activation response in patients with Hymenoptera anaphylaxis. [PDF]

open access: yesFront Allergy
Aigner S   +9 more
europepmc   +1 more source

The PGD<sub>2</sub>/DP2 axis promotes pro-inflammatory responses but attenuates an antigen-presenting role of human basophils. [PDF]

open access: yesCommun Biol
Luo J   +12 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy